{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:24:47Z","timestamp":1782217487919,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yunnan health training project of high level talents","award":["No. H-2019027"],"award-info":[{"award-number":["No. H-2019027"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82060613"],"award-info":[{"award-number":["No. 82060613"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23288-w","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:50:06Z","timestamp":1748677806000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Healthcare-seeking pathway and delay analysis of rifampicin-resistant tuberculosis patient in Southwestern China"],"prefix":"10.1186","volume":"25","author":[{"given":"Yunbin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haohao","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,31]]},"reference":[{"key":"23288_CR1","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"key":"23288_CR2","unstructured":"Li R, Ruan Y et al. WHO method for estimating the number of rifampicin resistant tuberculosis patients. Chin J Antituberculosis 2023,45(03):328."},{"issue":"12","key":"23288_CR3","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/trstmh\/trac054","volume":"116","author":"OA Adejumo","year":"2022","unstructured":"Adejumo OA, Daniel O, Adepoju VA, Onoh MO, Sokoya OD, Abdur-Razzaq H, Moronfolu O, Oyadotun OM, Olusola-Faleye B. Pretreatment attrition and treatment initiation delay among rifampicin-resistant tuberculosis patients in Lagos, Nigeria: a retrospective cohort study. Trans R Soc Trop Med Hyg. 2022;116(12):1154\u201361.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"23288_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4269\/ajtmh.18-0001","volume":"99","author":"SE Saqib","year":"2018","unstructured":"Saqib SE, Ahmad MM, Amezcua-Prieto C, Virginia MR. Treatment delay among pulmonary tuberculosis patients within the Pakistan National tuberculosis control program. Am J Trop Med Hyg. 2018;99(1):143\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"suppl7","key":"23288_CR5","doi-asserted-by":"publisher","first-page":"S686","DOI":"10.1093\/infdis\/jix388","volume":"216","author":"C Hanson","year":"2017","unstructured":"Hanson C, Osberg M, Brown J, Durham G, Chin DP. Finding the missing patients with tuberculosis: lessons learned from Patient-Pathway analyses in 5 countries. J Infect Dis. 2017;216(suppl7):S686\u201395.","journal-title":"J Infect Dis"},{"key":"23288_CR6","doi-asserted-by":"publisher","first-page":"101e6","DOI":"10.1093\/inthealth\/ihz036","volume":"12","author":"Q Yang","year":"2020","unstructured":"Yang Q, Tong Y, Yin X, Qiu L, Sun N, Zhao Y, et al. Delays in careseeking, diagnosis and treatment of patients with pulmonary tuberculosis in Hubei, China. Int Health. 2020;12:101e6.","journal-title":"Int Health"},{"key":"23288_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40249-020-0623-8","volume":"9","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu C-H, Wang X-M, Wang Z-Y, Wang Y-H, Zhang H, et al. Out-of-pocketpayments and economic consequences from tuberculosis care in EasternChina: income inequality. Infect Dis Poverty. 2020;9:14.","journal-title":"Infect Dis Poverty"},{"key":"23288_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12890-017-0551-y","volume":"17","author":"F Getnet","year":"2017","unstructured":"Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis ofpulmonary tuberculosis in low- and middle-income settings: systematic review and meta-analysis. BMC Pulmon Med. 2017;17:202.","journal-title":"BMC Pulmon Med"},{"key":"23288_CR9","unstructured":"Wei CHEN, Yin-yin XIA, Tao LI, Hui CHEN. Analysis for the global and China TB epidemic situation in 2015. J Tuberculosis Lung Disease, 2016(01): 32\u20136."},{"key":"23288_CR10","unstructured":"Meng Tang. The effect of DOTS strategy implementation and the treatment delay and its influencing factors of tuberculosis in high endemic area of Yunnan Province. Kunming Medical University; 2016."},{"issue":"10","key":"23288_CR11","first-page":"1025","volume":"41","author":"Chinese Antituberculosis Associatio","year":"2019","unstructured":"Chinese Antituberculosis Association. Guidelines for chemotherapy of drug resistant tuberculosis (2019). J Chin Antituberculosis Association. 2019;41(10):1025\u201373.","journal-title":"J Chin Antituberculosis Association"},{"issue":"12","key":"23288_CR12","first-page":"933","volume":"31","author":"lin Xu","year":"2015","unstructured":"Xu lin, Lianyong C, Li M. Drug resistance surveillance of tuberculosis in Yunnan Province. J Prev Med Inform. 2015;31(12):933\u20137.","journal-title":"J Prev Med Inform"},{"issue":"24","key":"23288_CR13","first-page":"4507","volume":"47","author":"YUAN Chen-yu","year":"2020","unstructured":"Chen-yu YUAN, lian-yong CHEN, Xing YANG, Yun-bin YANG, Jin-ou CHEN. YE Jin-xin, XU Lin. Analysis of the trend of rifampicin drug-resistant among pulmonary tuberculosis patients in Yunnan Province. Mod Prev Med. 2020;47(24):4507\u201310.","journal-title":"Mod Prev Med"},{"key":"23288_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2334-6-33","volume":"6","author":"MG Farah","year":"2006","unstructured":"Farah MG, Rygh JH, Steen TW, Selmer R, Heldal E, Bjune G. Patient and health care system delays in the start of tuberculosis treatment in Norway. BMC Infect Dis. 2006;6:33.","journal-title":"BMC Infect Dis"},{"key":"23288_CR15","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1186\/s12913-018-3077-y","volume":"18","author":"SD Sidharta","year":"2018","unstructured":"Sidharta SD, Yin JDC, Yoong JSY, Khan MS. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: A cross-sectional study in Yangon, Myanmar. BMC Health Serv Res. 2018;18:3077.","journal-title":"BMC Health Serv Res"},{"key":"23288_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12916-019-1271-3","volume":"17","author":"AL Stangl","year":"2019","unstructured":"Stangl AL, Earnshaw VA, Logie CH, Van Brakel W, Simbayi LC, Barr\u00e9 I, et al. The health stigma and discrimination framework: A global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas. BMC Med. 2019;17:13.","journal-title":"BMC Med"},{"key":"23288_CR17","doi-asserted-by":"publisher","first-page":"e004766","DOI":"10.1136\/bmjopen-2013-004766","volume":"4","author":"S Hossain","year":"2014","unstructured":"Hossain S, Zaman K, Quaiyum A, Banu S, Husain A, Islam A, et al. Care seeking in tuberculosis: results from a countrywide cluster randomized survey in Bangladesh. BMJ Open. 2014;4:e004766.","journal-title":"BMJ Open"},{"key":"23288_CR18","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1186\/s12879-018-3430-0","volume":"18","author":"KATM Ehsanul Huq","year":"2018","unstructured":"Ehsanul Huq KATM, Moriyama M, Zaman K, Chisti MJ, Long J, Islam A, et al. Health-seeking behavior and delayed management of tuberculosis patients in rural Bangladesh. BMC Infect Dis. 2018;18:3430.","journal-title":"BMC Infect Dis"},{"key":"23288_CR19","doi-asserted-by":"crossref","unstructured":"Law S, Piatek AS, Vincent C, Oxlade O, Menzies D. Emergence of drug resistance in patients with tuberculosis cared for by the Indian health-care system: a dynamic modelling study. Lancet Public Health. 2017.","DOI":"10.1016\/S2468-2667(16)30035-4"},{"issue":"6","key":"23288_CR20","doi-asserted-by":"publisher","first-page":"e002187","DOI":"10.1136\/bmjgh-2019-002187","volume":"5","author":"CC Ku","year":"2020","unstructured":"Ku CC, Chen CC, Dixon S, Lin HH, Dodd PJ. Patient pathways of tuberculosis care-seeking and treatment: an individual-level analysis of National health insurance data in Taiwan. BMJ Glob Health. 2020;5(6):e002187.","journal-title":"BMJ Glob Health"},{"key":"23288_CR21","volume-title":"Yunnan statistical yearbook 2010","author":"National Bureau of Statistics","year":"2010","unstructured":"National Bureau of Statistics. Yunnan statistical yearbook 2010. Beijing: National Bureau of Statistics; 2010."},{"key":"23288_CR22","first-page":"203","volume":"12","author":"Y Li Ying","year":"2005","unstructured":"Li Ying Y, Lijun T. Investigation on the current status and sustainable development of disease prevention and control institutions in Yunnan Province. Practical Prev Med. 2005;12:203\u20134.","journal-title":"Practical Prev Med"},{"issue":"10","key":"23288_CR23","first-page":"1166","volume":"46","author":"S Ruan Yunzhou","year":"2024","unstructured":"Ruan Yunzhou S, Hui weiZ. Zhaoyanlin. Historical evolution and prospect of rifampicin-resistant tuberculosis prevention and control in China. Chin J Antituberculosis. 2024;46(10):1166\u201370.","journal-title":"Chin J Antituberculosis"},{"issue":"1","key":"23288_CR24","doi-asserted-by":"publisher","first-page":"e170718","DOI":"10.1371\/journal.pone.0170718","volume":"12","author":"Z Xu","year":"2017","unstructured":"Xu Z, et al. Reasons for non-enrollment in treatment among multi-drug resistant tuberculosis patients in Hunan Province, China. PLoS ONE. 2017;12(1):e170718.","journal-title":"PLoS ONE"},{"key":"23288_CR25","unstructured":"China Center for Disease Control and prevention. Technical specification for tuberculosis control and prevention in China. (2020 Edition). Beijing: National Health and Health Committee Office, 2020."},{"key":"23288_CR26","unstructured":"Zhang L, Jin H et al. Reasons of the 34 Cases of MDR-TB Excluded from the Tuberculosis Control Project Supported by Global Fund. Reasons of the 34 cases of MDR-TB excluded from the tuberculosis control project supported by global fund.Chinese General Practice. 2017;20(17):2135\u20132138."},{"key":"23288_CR27","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/amiajnl-2013-002001","volume":"21","author":"F Huang","year":"2014","unstructured":"Huang F, Cheng S, Du X, et al. Electronic recording and reporting sys-tem for tuberculosis in China: experience and opportunities. J Am Med Inform Assoc. 2014;21:938\u201341.","journal-title":"J Am Med Inform Assoc"},{"key":"23288_CR28","unstructured":"Ministry of Health of the PRC. The measures for the administration of the hospital grade. 1989."},{"key":"23288_CR29","doi-asserted-by":"crossref","unstructured":"Zhang W, Ung COL, Lin G, Liu J, Li W, Hu H et al. Factors contributing topatients\u2019 preferences for primary health care institutions in China: a qualitative study. Front Public Health 2020;8.","DOI":"10.3389\/fpubh.2020.00414"},{"issue":"7","key":"23288_CR30","doi-asserted-by":"publisher","first-page":"e102884","DOI":"10.1371\/journal.pone.0102884","volume":"9","author":"A Asefa","year":"2014","unstructured":"Asefa A, Teshome W. Total delay in treatment among smear positive pulmonary tuberculosis patients in five primary health centers, Southern Ethiopia: a cross sectional study. PLoS ONE. 2014;9(7):e102884.","journal-title":"PLoS ONE"},{"key":"23288_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12879-014-0624-y","volume":"14","author":"TV Belkina","year":"2014","unstructured":"Belkina TV, Khojiev DS, Tillyashaykhov MN, Tigay ZN, Kudenov MU, Tebbens JD, Vlcek J. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study. BMC Infect Dis. 2014;14:624.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"23288_CR32","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/s41598-020-58690-4","volume":"10","author":"B Katende","year":"2020","unstructured":"Katende B, Esterhuizen TM, Dippenaar A, Warren RM. Rifampicin resistant tuberculosis in Lesotho: diagnosis, treatment initiation and outcomes. Sci Rep. 2020;10(1):1917.","journal-title":"Sci Rep"},{"key":"23288_CR33","unstructured":"Natural Earth Data. Free vector and raster map data. Nat Earth. (2023)."},{"issue":"3","key":"23288_CR34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0277-9536(83)90248-4","volume":"17","author":"A Kroeger","year":"1983","unstructured":"Kroeger A. Anthropological and socio-medical health care research in developing countries. Soc Sci Med. 1983;17(3):147\u201361.","journal-title":"Soc Sci Med"},{"issue":"suppl7","key":"23288_CR35","doi-asserted-by":"publisher","first-page":"S679","DOI":"10.1093\/infdis\/jix387","volume":"216","author":"CL Hanson","year":"2017","unstructured":"Hanson CL, Osberg M, Brown J, Durham G, Chin DP. Conducting Patient-Pathway analysis to inform programming of tuberculosis services: methods. J Infect Dis. 2017;216(suppl7):S679\u201385.","journal-title":"J Infect Dis"},{"issue":"8","key":"23288_CR36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1473-3099(13)70130-0","volume":"13","author":"D Falzon","year":"2013","unstructured":"Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC. Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis. 2013;13(8):690\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"23288_CR37","doi-asserted-by":"publisher","first-page":"e3173","DOI":"10.1371\/journal.pone.0003173","volume":"3","author":"P O\u2019Riordan","year":"2008","unstructured":"O\u2019Riordan P, Schwab U, Logan S, Cooke G, Wilkinson RJ, Davidson RN, Bassett P, Wall R, Pasvol G, Flanagan KL. Rapid molecular detection of rifampicin resistance facilitates early diagnosis and treatment of multi-drug resistant tuberculosis: case control study. PLoS ONE. 2008;3(9):e3173.","journal-title":"PLoS ONE"},{"issue":"7","key":"23288_CR38","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cmi.2020.12.031","volume":"27","author":"L Zhang","year":"2021","unstructured":"Zhang L, Weng TP, Wang HY, Sun F, Liu YY, Lin K, Zhou Z, Chen YY, Li YG, Chen JW, Han LJ, Liu HM, Huang FL, Cai C, Yu HY, Tang W, Huang ZH, Wang LZ, Bao L, Ren PF, Deng GF, Lv JN, Pu YL, Xia F, Li T, Deng Q, He GQ, Li Y, Zhang WH. Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China. Clin Microbiol Infect. 2021;27(7):1000\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"23288_CR39","doi-asserted-by":"publisher","first-page":"e0152287","DOI":"10.1371\/journal.pone.0152287","volume":"11","author":"N Mistry","year":"2016","unstructured":"Mistry N, Rangan S, Dholakia Y, Lobo E, Shah S, Patil A. Durations and delays in care seeking, diagnosis and treatment initiation in uncomplicated pulmonary tuberculosis patients in Mumbai, India. PLoS ONE. 2016;11(3):e0152287.","journal-title":"PLoS ONE"},{"key":"23288_CR40","first-page":"86e8","volume":"2","author":"Ministry of Health of the PRC","year":"2013","unstructured":"Ministry of Health of the PRC. Management of prevention and treatment oftuberculosis in China. Chin J Rural Med Pharm. 2013;2:86e8.","journal-title":"Chin J Rural Med Pharm"},{"issue":"3","key":"23288_CR41","doi-asserted-by":"publisher","first-page":"e0264252","DOI":"10.1371\/journal.pone.0264252","volume":"17","author":"N Soltobekova","year":"2022","unstructured":"Soltobekova N, Kozukeev T, Yiehdego G, Labib F, Hovhannesyan A, Rossi R. Time to start of tuberculosis treatment in penitentiary system of Kyrgyz Republic: A retrospective cohort study. PLoS ONE. 2022;17(3):e0264252.","journal-title":"PLoS ONE"},{"issue":"1","key":"23288_CR42","doi-asserted-by":"publisher","first-page":"ofv014","DOI":"10.1093\/ofid\/ofv014","volume":"2","author":"HS Cox","year":"2015","unstructured":"Cox HS, Daniels JF, Muller O, Nicol MP, Cox V, van Cutsem G, Moyo S, De Azevedo V, Hughes J. Impact of decentralized care and the Xpert MTB\/RIF test on Rifampicin-Resistant tuberculosis treatment initiation in Khayelitsha, South Africa. Open Forum Infect Dis. 2015;2(1):ofv014.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"23288_CR43","doi-asserted-by":"publisher","first-page":"e0213017","DOI":"10.1371\/journal.pone.0213017","volume":"14","author":"AY Soeroto","year":"2019","unstructured":"Soeroto AY, Lestari BW, Santoso P, Chaidir L, Andriyoko B, Alisjahbana B, van Crevel R, Hill PC. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study. PLoS ONE. 2019;14(2):e0213017.","journal-title":"PLoS ONE"},{"issue":"4","key":"23288_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5588\/ijtld.17.0452","volume":"22","author":"KKK Htet","year":"2018","unstructured":"Htet KKK, Soe KT, Kumar AMV, Saw S, Win Maung HM, Myint Z, Khine TMM, Aung ST. Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment? Int J Tuberc Lung Dis. 2018;22(4):385\u201392.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"23288_CR45","first-page":"1031","volume":"45","author":"Y Lv Tong","year":"2023","unstructured":"Lv Tong Y, Yunbin P, Ying, et al. Analysis of economic burden and influencing factors of rifampin-resistant pulmonary tuberculosis in Yunnan Province. Chin J Antituberculosis. 2023;45(11):1031\u20137.","journal-title":"Chin J Antituberculosis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23288-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23288-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23288-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T07:50:12Z","timestamp":1748677812000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23288-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23288"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23288-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was consulted to \u201cthe ethics committees of Yunnan Center for Disease Control and Prevention\u201d (Ethical review approval document 2023-34). We informed consent to participate was obtained from all of the participants in the study. The study did not include any data of patients\u2019 personal information, including name, identity information, address, telephone number, etc. Our study complies with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2019"}}